General Medicine · Medical Literature
From Silicon Valley to the Vatican—The Expanding Debate on AI Ethics
Abstract
JAMA+ AI Editor in Chief Roy Perlis, MD, MSc, and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, spoke about the values that shape AI systems and how these values may determine AI’s role in health care and public life for JAMA+ AI Conversations.
Clinical relevance
This JAMA+ AI Conversations editorial addresses the urgent and evolving question of whose values should govern AI systems deployed in health care and public life — a gap that grows more consequential as AI tools are integrated into clinical decision-making, diagnostics, and patient communication. The piece is timely given the convergence of industry-driven AI ethics frameworks (e.g., from major tech firms) and faith-based moral frameworks (e.g., the Vatican's 'Antiqua et Nova' and Rome Call for AI Ethics), which offer competing or complementary lenses for clinicians and health systems navigating AI adoption. Physicians and health system leaders should engage with this debate now, as the values embedded in AI systems will directly shape equity, autonomy, and the doctor-patient relationship.
Key findings
NOTE: This article is a podcast editorial/commentary (JAMA+ AI Conversations), not an original empirical study. No quantitative data, effect sizes, confidence intervals, p-values, or NNT/NNH values are reported. The following are the substantive conceptual points discussed, clearly labeled as non-quantitative: 1. The editors discuss how Anthropic's participation in Vatican presentations signals a broadening of AI ethics discourse beyond Silicon Valley's utilitarian/efficiency-centered frameworks toward dignity- and common-good-centered frameworks. 2. The conversation highlights that the values encoded into AI systems — whether profit-driven, secular, or theologically grounded — will determine AI's role in health care and public life. 3. The debate reflects a growing recognition that no single institutional actor (tech industry, government, or religion) holds a monopoly on AI ethics, and multi-stakeholder dialogue is emerging as necessary. 4. The Vatican's 'Antiqua et Nova' (2025) and related documents are referenced as examples of non-industry ethical frameworks that warn against AI concentration of power, erosion of human dignity, and health care inequity amplification. 5. The piece underscores that AI ethics is not merely a technical or regulatory matter but a deeply values-laden question with direct implications for clinical care, patient relationships, and health equity. 6. No specific clinical trial data, statistical analyses, or patient-level outcomes are presented — this is a limitation of this article type for evidence-based practice purposes.
Practice implications
Clinicians and health system leaders should actively participate in institutional and national discussions about the ethical frameworks guiding AI procurement and deployment, rather than treating AI adoption as a purely technical decision. When evaluating AI tools for clinical use, practitioners should scrutinize the value assumptions embedded in those systems — particularly with respect to equity, transparency, and preservation of the therapeutic relationship — recognizing that industry-developed ethics frameworks may not align with patient-centered or justice-oriented priorities. Given the absence of original empirical data in this piece, no specific changes to patient selection, dosing, or monitoring protocols can be derived; its primary value lies in orienting clinicians to the broader sociotechnical and ethical landscape shaping AI in medicine.